As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...